Request Trial

Pharma news

Reset all filters
Geography
Company
Refine search
Bausch reaches deal with competitor over IBS drug generic
Americas
Bausch reaches deal with competitor over IBS drug generic
According to the settlement, MSN can maintain its challenge to several Bausch patents, while the details around potential product launch timings are unknown.   7 April 2026
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
After years of strict patent rules, Argentina is changing course. New IP reforms are putting the country back on the map, but how companies handle the transition will matter.   1 April 2026
IndiaMart v CDSCO: A test of intermediary liability
Asia
IndiaMart v CDSCO: A test of intermediary liability
The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar.   31 March 2026
Europe
UK court deals blow to Spanish pharma’s SPC bid for contraceptive
The drugmaker’s attempt to extend protection for a fast-growing oestrogen-free contraceptive ran into a landmark EU ruling, with the court not persuaded to read it narrowly.   24 March 2026
Europe
EPO reports record patent filings, but pharma and biotech lag
The European Patent Office’s Technology Dashboard reveals only a slight increase in medtech filings, and drops in biotech and pharma, against an overall healthy backdrop.   24 March 2026
Pharma
Part II: The race to replace semaglutide heats up
With Novo Nordisk's core semaglutide patent expired in India last week, the company that built one of the most successful drugs in pharmaceutical history is already fighting on a new front. So what comes next?   23 March 2026
Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
Although the court agreed that the tech giant misappropriated some of Masimo’s information related to pulse oximetry technology, Apple is not barred from using it, says a California judge.   19 March 2026
Pharma
Sandoz strikes fresh biosimilar deal with South Korean biotech
The Swiss generics giant secures global commercialisation rights as partnership targets multi-billion-dollar loss-of-exclusivity opportunity.   19 March 2026
Pharma
INTA: ‘New normal’ for in-house counsel as budgets fall
Research from the International Trademark Association finds in-house counsel taking on more strategic work while facing shrinking budgets, prompting a shift towards alternative billing and greater use of AI.   16 March 2026
Americas
Mylan withdraws defence claims against Novo in Wegovy dispute
A proposed judgment by the rivals would extend the period in which Mylan is barred from obtaining regulatory approval for its generic of the weight-loss injectable.   13 March 2026